Peer Review History
| Original SubmissionJuly 3, 2022 |
|---|
|
PONE-D-22-18819Tailoring Interventions to Suit Self-Reported Format Preference Does Not Decrease Vaccine HesitancyPLOS ONE Dear Dr. Mäki, Thank you for submitting your manuscript to PLOS ONE. After careful consideration, we feel that it has merit but does not fully meet PLOS ONE’s publication criteria as it currently stands. Therefore, we invite you to submit a revised version of the manuscript that addresses the points raised during the review process.Please ensure that your decision is justified on PLOS ONE’s publication criteria and not, for example, on novelty or perceived impact. Please submit your revised manuscript by Nov 26 2022 11:59PM. If you will need more time than this to complete your revisions, please reply to this message or contact the journal office at plosone@plos.org. When you're ready to submit your revision, log on to https://www.editorialmanager.com/pone/ and select the 'Submissions Needing Revision' folder to locate your manuscript file. Please include the following items when submitting your revised manuscript:
If you would like to make changes to your financial disclosure, please include your updated statement in your cover letter. Guidelines for resubmitting your figure files are available below the reviewer comments at the end of this letter. If applicable, we recommend that you deposit your laboratory protocols in protocols.io to enhance the reproducibility of your results. Protocols.io assigns your protocol its own identifier (DOI) so that it can be cited independently in the future. For instructions see: https://journals.plos.org/plosone/s/submission-guidelines#loc-laboratory-protocols. Additionally, PLOS ONE offers an option for publishing peer-reviewed Lab Protocol articles, which describe protocols hosted on protocols.io. Read more information on sharing protocols at https://plos.org/protocols?utm_medium=editorial-email&utm_source=authorletters&utm_campaign=protocols. We look forward to receiving your revised manuscript. Kind regards, Jonathan Jong, PhD Academic Editor PLOS ONE Journal Requirements: When submitting your revision, we need you to address these additional requirements. 1. Please ensure that your manuscript meets PLOS ONE's style requirements, including those for file naming. The PLOS ONE style templates can be found at https://journals.plos.org/plosone/s/file?id=wjVg/PLOSOne_formatting_sample_main_body.pdf and 2. Please provide additional details regarding participant consent. In the ethics statement in the Methods and online submission information, please ensure that you have specified what type you obtained (for instance, written or verbal, and if verbal, how it was documented and witnessed). If your study included minors, state whether you obtained consent from parents or guardians. If the need for consent was waived by the ethics committee, please include this information. 3. Thank you for stating the following financial disclosure: “This project has received funding from the European Union’s Horizon 2020 research and innovation program under grant agreement No 964728 (JITSUVAX). KOM was funded by the Faculty of Social Sciences at the University of Turku (www.utu.fi/en/university/faculty-of-social-sciences). JKK and KOM received funding from the Strategic Research Council’s LITERACY program (Academy of Finland grant number: 335233). AS was funded by the Academy of Finland (grant number: 316004; www.aka.fi/en/). SL also acknowledges funding from the Humboldt Foundation Germany through a research award. NO” Please state what role the funders took in the study. If the funders had no role, please state: "The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript." If this statement is not correct you must amend it as needed. Please include this amended Role of Funder statement in your cover letter; we will change the online submission form on your behalf. 4. Please upload a new copy of Figure 1 as the detail is not clear. Please follow the link for more information: " ext-link-type="uri" xlink:type="simple">https://blogs.plos.org/plos/2019/06/looking-good-tips-for-creating-your-plos-figures-graphics/" https://blogs.plos.org/plos/2019/06/looking-good-tips-for-creating-your-plos-figures-graphics/ [Note: HTML markup is below. Please do not edit.] Reviewers' comments: Reviewer's Responses to Questions Comments to the Author 1. Is the manuscript technically sound, and do the data support the conclusions? The manuscript must describe a technically sound piece of scientific research with data that supports the conclusions. Experiments must have been conducted rigorously, with appropriate controls, replication, and sample sizes. The conclusions must be drawn appropriately based on the data presented. Reviewer #1: Partly Reviewer #2: Yes Reviewer #3: Yes ********** 2. Has the statistical analysis been performed appropriately and rigorously? Reviewer #1: Yes Reviewer #2: Yes Reviewer #3: Yes ********** 3. Have the authors made all data underlying the findings in their manuscript fully available? The PLOS Data policy requires authors to make all data underlying the findings described in their manuscript fully available without restriction, with rare exception (please refer to the Data Availability Statement in the manuscript PDF file). The data should be provided as part of the manuscript or its supporting information, or deposited to a public repository. For example, in addition to summary statistics, the data points behind means, medians and variance measures should be available. If there are restrictions on publicly sharing data—e.g. participant privacy or use of data from a third party—those must be specified. Reviewer #1: Yes Reviewer #2: Yes Reviewer #3: Yes ********** 4. Is the manuscript presented in an intelligible fashion and written in standard English? PLOS ONE does not copyedit accepted manuscripts, so the language in submitted articles must be clear, correct, and unambiguous. Any typographical or grammatical errors should be corrected at revision, so please note any specific errors here. Reviewer #1: Yes Reviewer #2: Yes Reviewer #3: Yes ********** 5. Review Comments to the Author Please use the space provided to explain your answers to the questions above. You may also include additional comments for the author, including concerns about dual publication, research ethics, or publication ethics. (Please upload your review as an attachment if it exceeds 20,000 characters) Reviewer #1: Overall, I found the paper well-written and based on a theoretically and practically interesting idea. The author did a good job explaining the main idea in the introduction, clearly describing the experimental and statistical procedure, and including two sets of experimental stimuli (COVID vaccines and influenza vaccines) for replication. Despite many things to like about this paper, I do have several major concerns and suggestions for possible improvement. I feel the literature review could be much more expanded to properly theorize the concepts of interest and predicted effects. Specifically, although the author did a great job reviewing the most recent and relevant empirical evidence regarding statistical vs. anecdotal messages and tailored intervention, the psychological mechanisms underlying their respective persuasive advantages could be briefly explained so that readers have adequate knowledge of why their effects are worth testing. Moreover, some of the outcome variables (except most obvious ones such as attitudes and intentions) should be properly defined and their connection to narrative and/or tailored persuasion can be explained. This would justify why they were studied in the research. And it could perhaps be done as the author explains the mechanisms of narrative and tailored effects. For example, narratives are considered to induce less audience reactance (frustration) and tailored messages are considered to be more relevant. Relatedly, a list of hypotheses should be developed based on reviewed literature and logical reasoning. This helps readers clearly understand the aims of the statistical tests. I am concerned about the measures used in the study. Most of the measures were not from established scales (Although I applauded the effort to develop and validate the format preference scale). Some of the measures used single items (e.g., relevance, helpfulness, frustration, intention); and some apparently lack face validity. For example, the vaccine attitudes measure included perceived threat of the disease and perceived ease of vaccination effort. Although the author did a CFA to make sure the statistical loadings made sense and removed the effort item, I don’t see how the threat item contribute to the operationalization of vaccine attitudes in a theoretical sense. Perceived threat is a conceptually distinct variable. The research yielded many null findings. As the author did not formally theorize and propose a list of hypotheses, it is relatively difficult to judge if these findings were aligned with the expectations and what their theoretical implications were. I’m okay with null findings but they would be better grounded in theories. Otherwise, I would have questions about the actual contribution of the study to knowledge. In my opinion, the scale development makes a better contribution to the literature on message format than the null findings actually reported in the paper. I wonder if the manuscript could be restructured to report both. I do see some of the findings in the scale development section help explain some of the null findings. For example, preference for anecdotal messages was negatively related to some of the outcome variables directly. The third variable here might be trust in medicine or government. This variable might be negatively related to anecdotal preference and positively related to vaccination outcomes. Thus, the author observed the reported negative association. I also think that trust should be controlled in analyses if it was measured in the experiments to rule out the possibility. Correspondingly, if the scale development is included as a first study, a better job needs to be done to conceptualize format preference in the literature review. Of course, I understand whether or not to do this depends on the length limit. But I think this presents a better contribution and could be done by reducing the descriptions of the statistical procedures. Those parts may be better included in supplemental materials or footnotes to save space for important findings and theory development. I also listed my other thoughts and suggestions: Please provide justification for using a convenient sample recruited on social media. Please explain why 80% of likelihood to get vaccinated was used as a cut-off point. Please discuss how measuring vaccine attitudes prior to message exposure influence narrative persuasion (known to be more powerful when persuasive intent is implicit) and potential testing effects. Any control variables included? For example, prior vaccination status, trust in science/medicine/government, etc. Please explain why photos were not used in the statistical intervention but in the control material and its possible confounding effect. The message details in Figure 1 were not readable. Please provide the full messages in supplemental materials along with English translations. Please include the mean tables and descriptive statistics of the variables (reliability, mean, SD) in the main text. Please revisit the discussion after putting together a list of hypotheses and discuss the theoretical implications. Please acknowledge limitations related to the sample and measures. Reviewer #2: Timely topic to examineas cuntries explore how best to catch up routime immunization as wellas immunize adults with flu and COVID vaccines. A concern from the begining - vaccine decsion making has many inlfuences - ie many factors inlfuence - this study examines one set of factors stats vs anecdote - imp point to understand BUT in real world there would be context, what others in social network doing, personal past expereinces , etcetc that can inlfuence that decsion. Not sure is possible to keep all of these bkg factors similar across a study.However- helpful to know how this one variable - stats vs story impacted in Methods - line 148-9 recruitment - do not know bkg in Finland to know access and use of these platforsm by elderly for example - line 177 - how did you measure frustration? Is it a validated tecnique? - Figure 1 - these were unreadable even when a snipped them and increased the size ....are they in Finish? Figure needs ot redone in font sie that is readable - a key element in the sytudy is the intervention and that is not clear for review as presented - line 200-220- pre post measures - has been controversy in literatire whether "intent" to accpe timmunization is strngly correalted with action . So imp here to note this, justfy why chose intent and also that prepost survey questions validated . The next section dicussed reliability BUT that is to intent not in actual uptake - do you know if intent measures her are linked to actual uptakr ? Lines 229 -231- this is not a surprise as negative st=ciks more than positive and framing matters - why is so key to be able to actually read the anecdotes to see how frmaed and whther +ve or negative lines 236 -242...again were these validated ? Lines 264-5. " strongly skewed and even slightly bimodal at times" one might have exepcted this esp if negative anexdotes vs positive or neutral ie stats given the stikiness of negative stories - helpful to see adjusted for this Results 305-308....for me this is not a great surproise- why wanted to know if had validated before actual study 302-319. this is so imp and strengthens the study results 326-328 - since vaccine decsion making is influenced by many factors - perhaps this is not such a surprise line 359-364...there was no both interventions together vs control - that would have been interesting ....not clear in methods why this was not another arm of the study.....esp as you found that more participants preferred anecdotes, the more their intentions to take a third COVID-19 vaccine increased by the statistical intervention. Does this notagree with marketing evidence that data tells but stories sell and if put together even more powerful? Why an arm that had both would have added value Lines 396 to 400 - in this 25 % negative impact gorup - were these negative data and/or anecdotes ie the stickiness issue ? Flu - very helpful to see the flu data paralelled COVID data in some waysbut differed in other. This may well reflect different perceived context and hence differing importance between flua nd COVID vaccines, diff past experiences etcetc ie th emyriad other factors know impacts vaccien decsion making . This strengthen the paper Discussion 527-530. Most studies of single interventions not change vaccine acceptance much - so not a big surprise here . Do wish had had 4th arm of stats + anecdote vs control 576 -579 - yes context and expereince do matter .... 591-595- as I could not read the anecdotes - don't know but likley correct 607 -608 might want to be more nuanced than this - stats or anecdotes indodulally did not appear to be effective in pop where not very postive torwards these vaccines. 612-615- not sure can go that far- as never tested the two together - that has to eb one of the conlusions that that nees to be done Reviewer #3: Review for PONE-D-22-18819 This paper has two aims. First it develops a scale that aims to measure self-reported preferences for statistical or anecdotal information amongst vaccine hesitant individuals. Second it tests the interaction between format preferences (statistical or anecdotal information) and format type (statistical or anecdotal) on vaccine attitudes and intentions amongst vaccine deniers. The authors predicted that congruent information preference and intervention format (prefer statistical--informed statistical vs. preferred anecdotal--informed anecdotal) would boost vaccine intentions amongst vaccine hesitant participants. They found no support for their predictions. A non-predicted finding was that participants with preferences for anecdotes were more frustrated by the interventions regardless of format type (statistical, anecdotal) and found the interventions less helpful and relevant. Furthermore, in contrast to the predictions, the authors found that statistical information increased vaccine intentions of participants with higher preferences for anecdotal information. The topic of the paper is timely. Theoretical background It is unclear what the theoretical support for the predictions is. Why did the authors theoretically predict that interventions will be more effective in promoting vaccine intentions when the intervention format was congruent with the participants' format preference? And specifically, why did the authors predict this for vaccine denier? The paper would benefit from a clearer theoretical account. Without this it seems exploratory which also would be fine but then this needs to be clearly stated. Methods The preregistration OSF link presented in the paper did not work (I only found a OSF link for the data). For future submissions, I recommend that the authors are careful about including a link in their method section that works. It is crucial in judging the work. As a reviewer I need to understand whether the predictions made in the paper were a-priori or post-hoc, what inclusion and exclusion criteria were preregistered, whether the analyses were planned and what variables were used. I was unable to judge this as the link did not work. [Page 8, line 162 to 165] The power simulation presented in the paper seems undetailed. It would be helpful for the reader to include more details about what estimates were used and where they were based on. [Page 8, line 165 to 167] The exclusions of 843 participants is a very large part of the sample (43.4%). It would be important to understand whether this was preregistered and anticipated. But because the preregistration link did not work I am unable to judge this. Materials It is great that the authors included examples of the materials that were used, but they are not readable in the current format. It would be important to include them in a higher quality so people can read and judge them. This is especially important given the null effect of the present study, which is informative for people who might want to test a similar intervention. Discussion The authors might wish to be more careful about their conclusions. They could for example be more careful in their wording and include the following suggestion or something along those lines (see **WORDING BELOW**): [Page 30, line 526 to 528] “The present experiment consistently suggests that it is unlikely that tailoring vaccine hesitancy interventions according to format preferences **as measured in the present study with the present sample**,would enhance the efficacy of the interventions. I am wondering whether the intervention would be effective for uncertain participants. This group might benefit from tailored interventions. Is there a theoretical account that would suggest this? Best of luck with this research! ********** 6. PLOS authors have the option to publish the peer review history of their article (what does this mean?). If published, this will include your full peer review and any attached files. If you choose “no”, your identity will remain anonymous but your review may still be made public. Do you want your identity to be public for this peer review? For information about this choice, including consent withdrawal, please see our Privacy Policy. Reviewer #1: No Reviewer #2: No Reviewer #3: No ********** [NOTE: If reviewer comments were submitted as an attachment file, they will be attached to this email and accessible via the submission site. Please log into your account, locate the manuscript record, and check for the action link "View Attachments". If this link does not appear, there are no attachment files.] While revising your submission, please upload your figure files to the Preflight Analysis and Conversion Engine (PACE) digital diagnostic tool, https://pacev2.apexcovantage.com/. PACE helps ensure that figures meet PLOS requirements. To use PACE, you must first register as a user. Registration is free. Then, login and navigate to the UPLOAD tab, where you will find detailed instructions on how to use the tool. If you encounter any issues or have any questions when using PACE, please email PLOS at figures@plos.org. Please note that Supporting Information files do not need this step. |
| Revision 1 |
|
Tailoring interventions to suit self-reported format preference does not decrease vaccine hesitancy PONE-D-22-18819R1 Dear Dr. Mäki, We’re pleased to inform you that your manuscript has been judged scientifically suitable for publication and will be formally accepted for publication once it meets all outstanding technical requirements. Within one week, you’ll receive an e-mail detailing the required amendments. When these have been addressed, you’ll receive a formal acceptance letter and your manuscript will be scheduled for publication. An invoice for payment will follow shortly after the formal acceptance. To ensure an efficient process, please log into Editorial Manager at http://www.editorialmanager.com/pone/, click the 'Update My Information' link at the top of the page, and double check that your user information is up-to-date. If you have any billing related questions, please contact our Author Billing department directly at authorbilling@plos.org. If your institution or institutions have a press office, please notify them about your upcoming paper to help maximize its impact. If they’ll be preparing press materials, please inform our press team as soon as possible -- no later than 48 hours after receiving the formal acceptance. Your manuscript will remain under strict press embargo until 2 pm Eastern Time on the date of publication. For more information, please contact onepress@plos.org. Kind regards, Wojciech Trzebinski, Ph.D. Academic Editor PLOS ONE Additional Editor Comments (optional): Reviewers' comments: Reviewer's Responses to Questions Comments to the Author 1. If the authors have adequately addressed your comments raised in a previous round of review and you feel that this manuscript is now acceptable for publication, you may indicate that here to bypass the “Comments to the Author” section, enter your conflict of interest statement in the “Confidential to Editor” section, and submit your "Accept" recommendation. Reviewer #2: All comments have been addressed Reviewer #3: All comments have been addressed ********** 2. Is the manuscript technically sound, and do the data support the conclusions? The manuscript must describe a technically sound piece of scientific research with data that supports the conclusions. Experiments must have been conducted rigorously, with appropriate controls, replication, and sample sizes. The conclusions must be drawn appropriately based on the data presented. Reviewer #2: Yes Reviewer #3: Yes ********** 3. Has the statistical analysis been performed appropriately and rigorously? Reviewer #2: Yes Reviewer #3: Yes ********** 4. Have the authors made all data underlying the findings in their manuscript fully available? The PLOS Data policy requires authors to make all data underlying the findings described in their manuscript fully available without restriction, with rare exception (please refer to the Data Availability Statement in the manuscript PDF file). The data should be provided as part of the manuscript or its supporting information, or deposited to a public repository. For example, in addition to summary statistics, the data points behind means, medians and variance measures should be available. If there are restrictions on publicly sharing data—e.g. participant privacy or use of data from a third party—those must be specified. Reviewer #2: Yes Reviewer #3: Yes ********** 5. Is the manuscript presented in an intelligible fashion and written in standard English? PLOS ONE does not copyedit accepted manuscripts, so the language in submitted articles must be clear, correct, and unambiguous. Any typographical or grammatical errors should be corrected at revision, so please note any specific errors here. Reviewer #2: Yes Reviewer #3: Yes ********** 6. Review Comments to the Author Please use the space provided to explain your answers to the questions above. You may also include additional comments for the author, including concerns about dual publication, research ethics, or publication ethics. (Please upload your review as an attachment if it exceeds 20,000 characters) Reviewer #2: The study was never simple and hence the report was sometimes convoluted and hard to grasp. The changes in response to the reviewers' comments have made the paper much more accessible and the nuances more easily grasped. The report will add to the literature and further illustrates why simple solutions and easy leaps form previous data do not always pan out. The question challenged in this study needed an answer and sadly the negative finding may not be one many expected. Do hope the impact on actual uptake will be vetted at some point - not just intent Reviewer #3: The authors addressed all my comments in a thorough manner. I have no further comments. Thank you very much. ********** 7. PLOS authors have the option to publish the peer review history of their article (what does this mean?). If published, this will include your full peer review and any attached files. If you choose “no”, your identity will remain anonymous but your review may still be made public. Do you want your identity to be public for this peer review? For information about this choice, including consent withdrawal, please see our Privacy Policy. Reviewer #2: No Reviewer #3: No ********** |
| Formally Accepted |
|
PONE-D-22-18819R1 Tailoring interventions to suit self-reported format preference does not decrease vaccine hesitancy Dear Dr. Mäki: I'm pleased to inform you that your manuscript has been deemed suitable for publication in PLOS ONE. Congratulations! Your manuscript is now with our production department. If your institution or institutions have a press office, please let them know about your upcoming paper now to help maximize its impact. If they'll be preparing press materials, please inform our press team within the next 48 hours. Your manuscript will remain under strict press embargo until 2 pm Eastern Time on the date of publication. For more information please contact onepress@plos.org. If we can help with anything else, please email us at plosone@plos.org. Thank you for submitting your work to PLOS ONE and supporting open access. Kind regards, PLOS ONE Editorial Office Staff on behalf of Dr. Wojciech Trzebinski Academic Editor PLOS ONE |
Open letter on the publication of peer review reports
PLOS recognizes the benefits of transparency in the peer review process. Therefore, we enable the publication of all of the content of peer review and author responses alongside final, published articles. Reviewers remain anonymous, unless they choose to reveal their names.
We encourage other journals to join us in this initiative. We hope that our action inspires the community, including researchers, research funders, and research institutions, to recognize the benefits of published peer review reports for all parts of the research system.
Learn more at ASAPbio .